Contact Us
1 min read

Evidence Matters: Joel White of Marketcap Consultants

Link: https://ubc.com/insights/evidence-matters-joel-white-of-marketcap-consultants/

Recently, Aaron Berger, SVP of Evidence Development Solutions, had a chance to sit down and talk with Joel White of Marketcap consultants, to discuss the state of life science trends and the next wave of real world evidence generation. Joel has long been an important voice in the life sciences space, always with his finger on the pulse of our industry. Thanks so much to Joel for spending time with us and we look forward to future collaborations.

Other Recent Posts

View More
nanotechnology and abstract graphene structures
Press
November 20, 20256 min read

Datavant and UBC Partner to Transform Observational Research and Patient Access for Biopharmaceutical Sponsors

Datavant and United BioSource Corporation (UBC) have joined forces to transform late-phase research and patient access programs for biopharmaceutical sponsors. By combining Datavant’s privacy-first data connectivity with UBC’s expertise in specialty therapies, the partnership introduces two new offerings: Modern Observational Research Study Designs and Enhanced Patient Access Programs. These solutions aim to accelerate evidence generation, improve patient outcomes, and set a new standard for real-world research and access.
Above view of group of business persons in business meeting. Group of entrepreneurs on meeting in board room. Corporate business team on meeting in the office.
Press
August 11, 20254 min read

UBC Launches New Pharmacovigilance Reporting Capabilities

UBC launches new RxLogix pharmacovigilance reporting platform to enhance drug safety capabilities with advanced aggregate reporting, real-time analytics, and reduced regulatory risk for biopharmaceutical companies.
Two diverse professionals, a man and a woman, collaborate intently on a computer screen in a dimly lit office. The man points at the monitor while the woman observes.
Press
April 24, 20254 min read

UBC Named a Pharmacovigilance Leader in Everest Group PV Operations PEAK Matrix Assessment 2025

UBC has been recognized by Everest Group as a leader in its 2025 Pre-approval Pharmacovigilance (PV) PEAK Matrix®, and a major contender in the Post-approval category. The recognition highlights UBC’s strength in delivering innovative, compliant, and patient-focused PV solutions across the drug development lifecycle.

Want to know more about us?

Subscribe Now

Want to know more about us?

Subscribe Now

About us

Solutions

Insights

Resources

For HCPs

Clinical

Contact us

About UBC

Other

Evidence Development

Safety & Risk Management

Patient Access

Providers

Technology Solutions

The logo for UBC, which features a teal stylized swirling design on the left, followed by "UBC" in the same teal color.
©2025 United BioSource LLC, all rights reserved
UBC®, CLÆRITY®, SæfetyWorks®, ExpressConnect® and UBC Pathways® are trademarks of United BioSource LLC.
Twitter Linkedin
UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

  • Leverage automation to move fast
  • Always give customers a human to chat to
  • Automate customer support and close leads faster
Return to Homepage
Connect with Us on LinkedIn
UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.